Company
Melbourne, VIC
Every investor coverage indicates participated in a round Cylite raised.
Investors whose own portfolio pages list Cylite, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Main Sequence Ventures | its portfolio page ↗ |
Companies Cylite acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Cylite. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Deep-tech investor Main Sequence is seeking $400 million for a fourth fund, with $75 million already committed by the federal government, after two portfolio companies reached unicorn status this year.
Interview with Kylee Hall, chief executive of medical device maker Cylite, on joining the Main Sequence-backed company, scaling its team, and preparing a deep-tech healthcare business for a future sale.
Interview with Main Sequence Ventures partner Mike Zimmerman on backing deep-tech manufacturing spinouts from public research, its portfolio, Australia's venture market, and planned future investments.